Share
Abstracts accepted for publication
Rheumatoid arthritis - anti-TNF therapy
AB0268 Lack of correlation between golimumab exposure and selected safety events following intravenous or subcutaneous administration in an integrated analysis of phase 3 data in rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis